The recent Joe Rogan podcast appearance by actor Mel Gibson has sparked a surge in demand for an unconventional cancer treatment. Gibson's claim that he and his friends used an antiparasitic drug combination, Ivermectin-Benzimidazole, to treat their stage 4 cancer has led to a 2.5-fold increase in prescriptions for cancer patients. This trend raises important questions about the role of celebrity influence in healthcare decisions and the potential risks of off-label drug use. While laboratory and animal studies suggest these drugs may have anti-cancer properties, the required dose for even a small effect would be toxic for humans. This highlights the need for caution and further research before recommending such treatments. The study also underscores the importance of consulting qualified healthcare professionals for medical guidance, as off-label drug use can have serious consequences. The incident serves as a reminder that while celebrities may have a significant impact on public opinion, it is crucial to approach their recommendations with skepticism and critical thinking. The surge in demand for Ivermectin-Benzimidazole also raises concerns about the potential for misuse and the need for better regulation of off-label drug use. Overall, this incident serves as a cautionary tale about the dangers of relying on unproven treatments and the importance of evidence-based healthcare.
